Autologous Stem Cell Transplantation in Patients with Acute Myeloid Leukemia: a Single-Centre Experience

1. Apperley J, Carreras E, Gluckman E, Masszi T. The EBMT Handbook Haematopoietic Stem Cell Transplantation. 6th Revised Edition. 2012:317-326Search in Google Scholar

2. Tsimberidou AM, Stavroyianni N, Viniou N. Comparison of allogeneic stem cell transplantation, high-dose cytarabine, and autologous peripheral stem cell transplantation as postremission treatment in patients with de novo acute myelogenous leukemia. Cancer. 2003;97(7):1721-1731.10.1002/cncr.11240Search in Google Scholar

3. Büchner T, Berdel WE, Schoch C, et al. Double induction containing either two courses or one course of high-dose cytarabine plus mitoxantrone and postremission therapy by either autologous stem-cell transplantation or by prolonged maintenance for acute myeloid leukemia. J Clin Oncol. 2006; 24(16):2480-2489.10.1200/JCO.2005.04.5013Search in Google Scholar

4. Harousseau JL, Cahn JY, Pignon B, et al. Comparison of autologous bone marrow transplantation and intensive chemotherapy as postremission therapy in adult acute myeloid leukemia. Blood. 1997;90(8):2978-2986.Search in Google Scholar

5. Isidori A, Bonifazi F, Visani G, et al. Autologous stem cell transplantation for acute myeloid patients in first complete remission: a 10-year follow-up study of 118 patients. Haematologica. 2005;90:139-140.Search in Google Scholar

6. Suciu S, Mandelli F, de Witte T, et al. EORTC and GINEMA Leukemia Groups- Allogeneic compared with autologous stem cell transplantation in the treatment of patients younger than 46 years with acute myeloid leukemia(AML) in first comlete remission(CR1): an intention-to-treat analysis of EORTC/GIMEMA AML-10 trial. Blood. 2003;102:1232-1240.10.1182/blood-2002-12-3714Search in Google Scholar

7. Wang J, Ouyang J, Zhou R, et al. Autologous hematopoietic stem cell transplantation for acute myeloid leukemia in first complete remission: a meta-analysis of randomized trials. Acta Haematol. 2010;124(2):61-71.10.1159/000314273Search in Google Scholar

8. Gordon MY, Blackett NM, Lewis JL, et al. Evidence for a mechanism that can provide both short-term and longterm haemopoetic repopulation by a seemingly uniform population of primitive human haemopoetic precursor cells. Leukemia. 1995;9:1252-6.Search in Google Scholar

9. Villaon L, Odriozola J, Larana JG, et al. Autologous peripheral blood progenitor cell transplantation with <2x 10(6) CD34(+)/kg: an analysis of variables concerning mobilisation and engraftment. Hematol J. 2000;1: 374-81.10.1038/sj.thj.6200057Search in Google Scholar

10. Vellenga E, van Putten W, Ossenkoppele GJ, et al. Autologous peripheral blood stem cell transplantation for acute myeloid leukemia. Blood. 2011;118(23):6037-42.10.1182/blood-2011-07-370247Search in Google Scholar

11. Ferrara F. Renaissance of autologous stem cell transplantation for AML? The Lancet Oncology. 2012;13(2):121-3.10.1016/S1470-2045(11)70395-3Search in Google Scholar

12. Mehta J, Powles R, Sirhohi B, et al. Impact of cytogenetics on the outcome of autotransplantation for acute myeloid leukemia in first remission: is the benefit of intensive pre-transplant therapy limited to patients with good karyotypes. Blood. 2001;98(Suppl 1):716a.Search in Google Scholar

13. Linker C. The role of autologous transplantation for acute myeloid leukemia in first and second remission. Best Pract Res Clin Haematol. 2007;20:77-84. Review.10.1016/j.beha.2006.11.00717336257Search in Google Scholar

14. Gorin NC, Labopin M, Frassoni F, et al. Identical outcome after autologous or allogeneic genoidentical hematopoietic stem-cell transplantation in first remission of acute myelocytic leukemia carrying inversion 16 or t(8;21): a retrospective study from the European Cooperative Group for Blood and Marrow Transplantation. J Clin Oncol. 2008;26:3183-3188.10.1200/JCO.2007.15.310618506024Search in Google Scholar

15. Thomas X, Suciu S, Rio B, et al. Autologous stem cell transplantation after complete remission and first consolidation in acute myeloid leukemia patients aged 61-70 years: results of the prospective EORTC-GIMEMA AML-13 study. Haematologica. 2007;92:389-396.10.3324/haematol.1055217339189Search in Google Scholar

16. Burnett AK, Mohite U. Treatment of older patients with acute myeloid leukemia-new agents. Semin Hemat. 2006;43:96-106.10.1053/j.seminhematol.2006.01.00316616043Search in Google Scholar